Find clinical trials for Non-Hodgkin Lymphoma in Durham, NC
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Hodgkin Lymphoma trials near Durham, NC, USA:
Study J2N-MC-JZ01 (JZ01) is an individual-study appendix (ISA) under master protocol J2N-MC-JZNY, and represents participants from the completed orig...
Phase 4
Durham, North Carolina, United States and 34 other locations
This study has 2 parts.The main aim of Part 1 is to check for side effects from TAK-007 in adults with relapsed or refractory (r/r) B-cell Non...
Phase 2
Durham, North Carolina, United States and 14 other locations
This is a Phase 1/1b, nonrandomized, open-label, parallel assignment, dose-escalation, and dose-expansion study to evaluate the safety and clinical a...
Phase 1
Durham, North Carolina, United States and 21 other locations
The primary purpose of the study is to evaluate whether biweekly administered XEMBIFY® plus Standard Medical Treatment (SMT) over a one-year period w...
Phase 3
Morrisville, North Carolina, United States and 56 other locations
This is an open-label, multi-center Phase 1/2 study of oral LOXO-305 (pirtobrutinib) in patients with CLL/SLL and NHL who have failed or are intolera...
Phase 1, Phase 2
Durham, North Carolina, United States and 55 other locations
DS-3201b is an experimental drug that is being investigated in clinical research.Adults with non-Hodgkin lymphoma (NHL) ma...
Phase 1
Durham, North Carolina, United States and 20 other locations
The study is focused on patients with diffuse large B-cell lymphoma (DLBCL) that have not been treated before (called "previously untreated"...
Phase 3
Durham, North Carolina, United States and 148 other locations
is focused on participants with previously untreated follicular lymphoma (a type of non-Hodgkin lymphoma or NHL)....
Phase 3
Chapel Hill, North Carolina, United States and 151 other locations
The master protocol study J2N-MC-JZNY provides a framework to enable the evaluation of the long-term safety and efficacy of pirtobrutinib after compl...
Phase 4
Durham, North Carolina, United States and 35 other locations
The study evaluates CLR 131 in children, adolescents, and young adults with relapsed or refractory malignant solid tumors and lymphoma and r...
Phase 1
Chapel Hill, North Carolina, United States and 7 other locations
Clinical trials
Research sites
Resources
Legal